These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 21622954)
21. ZINC--a free database of commercially available compounds for virtual screening. Irwin JJ; Shoichet BK J Chem Inf Model; 2005; 45(1):177-82. PubMed ID: 15667143 [TBL] [Abstract][Full Text] [Related]
22. Utilizing the intramolecular Fukuyama-Mitsunobu reaction for a flexible synthesis of novel heterocyclic scaffolds for peptidomimetic drug design. Zapf CW; Del Valle JR; Goodman M Bioorg Med Chem Lett; 2005 Sep; 15(18):4033-6. PubMed ID: 16002286 [TBL] [Abstract][Full Text] [Related]
23. Toward general methods of targeted library design: topomer shape similarity searching with diverse structures as queries. Andrews KM; Cramer RD J Med Chem; 2000 May; 43(9):1723-40. PubMed ID: 10794690 [TBL] [Abstract][Full Text] [Related]
24. Molecular mode of action of a covalently inhibiting peptidomimetic on the human calpain protease core. Li Q; Hanzlik RP; Weaver RF; Schönbrunn E Biochemistry; 2006 Jan; 45(3):701-8. PubMed ID: 16411745 [TBL] [Abstract][Full Text] [Related]
25. Discovery of novel anti-HIV-1 agents based on a broadly neutralizing antibody against the envelope gp120 V3 loop: a computational study. Andrianov AM; Kashyn IA; Tuzikov AV J Biomol Struct Dyn; 2014 Dec; 32(12):1993-2004. PubMed ID: 24251545 [TBL] [Abstract][Full Text] [Related]
26. Development and screening of a polyketide virtual library for drug leads against a motilide pharmacophore. Siani MA; Skillman AG; Carreras CW; Ashley G; Kuntz ID; Santi DV J Mol Graph Model; 2000; 18(4-5):497-511, 539-40. PubMed ID: 11143565 [TBL] [Abstract][Full Text] [Related]
27. Design and development of peptides and peptide mimetics as antagonists for therapeutic intervention. Mason JM Future Med Chem; 2010 Dec; 2(12):1813-22. PubMed ID: 21428804 [TBL] [Abstract][Full Text] [Related]
29. The practice of ring constraint in peptidomimetics using bicyclic and polycyclic amino acids. Hanessian S; Auzzas L Acc Chem Res; 2008 Oct; 41(10):1241-51. PubMed ID: 18646869 [TBL] [Abstract][Full Text] [Related]
30. SPIDR: small-molecule peptide-influenced drug repurposing. King MD; Long T; Pfalmer DL; Andersen TL; McDougal OM BMC Bioinformatics; 2018 Apr; 19(1):138. PubMed ID: 29661129 [TBL] [Abstract][Full Text] [Related]
31. EmPLiCS: an empirical approach for structure-based design of natural peptide drugs. Ishida H; Shirai T; Matsuda Y; Kato Y; Ohno M; Isaji T; Yamane T J Biochem; 2000 Oct; 128(4):561-74. PubMed ID: 11011138 [TBL] [Abstract][Full Text] [Related]
32. In silico fragment-mapping method: a new tool for fragment-based/structure-based drug discovery. Yamaotsu N; Hirono S J Comput Aided Mol Des; 2018 Nov; 32(11):1229-1245. PubMed ID: 30196523 [TBL] [Abstract][Full Text] [Related]
33. MIND-BEST: Web server for drugs and target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretical-experimental study of G3PDH protein from Trichomonas gallinae. González-Díaz H; Prado-Prado F; García-Mera X; Alonso N; Abeijón P; Caamaño O; Yáñez M; Munteanu CR; Pazos A; Dea-Ayuela MA; Gómez-Muñoz MT; Garijo MM; Sansano J; Ubeira FM J Proteome Res; 2011 Apr; 10(4):1698-718. PubMed ID: 21184613 [TBL] [Abstract][Full Text] [Related]
34. Protein ligand design: from phage display to synthetic protein epitope mimetics in human antibody Fc-binding peptidomimetics. Dias RL; Fasan R; Moehle K; Renard A; Obrecht D; Robinson JA J Am Chem Soc; 2006 Mar; 128(8):2726-32. PubMed ID: 16492060 [TBL] [Abstract][Full Text] [Related]
35. CS-MINER: A Tool for Association Mining in Binding-Database. Mani-Varnosfaderani A; Valadkhani A; Jalali-Heravi M Mol Inform; 2015 Apr; 34(4):185-96. PubMed ID: 27490165 [TBL] [Abstract][Full Text] [Related]
36. Design, structure-based focusing and in silico screening of combinatorial library of peptidomimetic inhibitors of Dengue virus NS2B-NS3 protease. Frecer V; Miertus S J Comput Aided Mol Des; 2010 Mar; 24(3):195-212. PubMed ID: 20306283 [TBL] [Abstract][Full Text] [Related]
37. 3D-QSAR study of corticotropin-releasing factor 1 antagonists and pharmacophore-based drug design. Ye Y; Liao Q; Wei J; Gao Q Neurochem Int; 2010 Jan; 56(1):107-17. PubMed ID: 19782115 [TBL] [Abstract][Full Text] [Related]
38. Combining ethnopharmacology and virtual screening for lead structure discovery: COX-inhibitors as application example. Rollinger JM; Haupt S; Stuppner H; Langer T J Chem Inf Comput Sci; 2004; 44(2):480-8. PubMed ID: 15032527 [TBL] [Abstract][Full Text] [Related]
39. MDockPeP: A Web Server for Blind Prediction of Protein-Peptide Complex Structures. Xu X; Zou X Methods Mol Biol; 2020; 2165():259-272. PubMed ID: 32621230 [TBL] [Abstract][Full Text] [Related]
40. LEAP into the Pfizer Global Virtual Library (PGVL) space: creation of readily synthesizable design ideas automatically. Hu Q; Peng Z; Kostrowicki J; Kuki A Methods Mol Biol; 2011; 685():253-76. PubMed ID: 20981528 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]